Merck to submit Cladribine for Euro registration
Posted: Fri Sep 11, 2015 5:48 am
German healthcare firm Merck has announced it is to submit its investigational treatment Cladribine Tablets for the treatment of relapsing MS for registration in Europe. The decision follows the company’s evaluation of new data and additional analyses of the compound’s benefit-risk profile....Read More - http://www.ms-uk.org/MSnews